Zambia

■Select Country

Small Scale Community Household Evaluation has been conducted in Zambia to evaluate VECTRON™ T500 residual efficacy applied on both concrete, mud and brick Community Household against pyrethroid susceptible Anopheles gambiae s.s. and resistant wild An. funestus s.l. It provided residual efficacy above 80% at the 120-hour mark during each monthly observation throughout the 12-month duration.

24-120 hours mosquito mortality tested in 30 min WHO cone bioassays

Cement walls

VECTRON™ T500

Positive control (PQ-listing product)

An. gambiae s.s. KISUMU:
Insecticide susceptible
Wild sampled An. funestus s.l.:
Resistant for pyrethroid

Mud walls

VECTRON™ T500

Positive control (PQ-listing product)

An. gambiae s.s. KISUMU:
Insecticide susceptible
Wild sampled An. funestus s.l.:
Resistant for pyrethroid

Brick walls

VECTRON™ T500

Positive control (PQ-listing product)

An. gambiae s.s. KISUMU:
Insecticide susceptible
Wild sampled An. funestus s.l.:
Resistant for pyrethroid
Tropical Diseases Research Centre
Study Type Small Scale Community Household Evaluation
Location Nchelenge district
Trial Year 2022-2023
Species An. gambiae s.s. KISUMU, Wild An. funestus
Substrate Concrete, Mud, Brick
Trial Institute (+ Researcher) Tropical Diseases Research Centre
Link to publication
Study Condition/Method 24-120 hour mosquito mortality tested in 30 min WHO cone bioassays in experimental huts
Study Status Finished
Observation Small Scale Community Household Evaluation has been conducted in Zambia to evaluate VECTRON™ T500 residual efficacy applied on both concrete, mud and brick hut against pyrethroid susceptible Anopheles gambiae s.s. and resistant wild An. funestus s.l. It maintained residual efficacy (>80%) throughout the twelve-month trial period on all substrates.
Explanation of Species Susceptible An. gambiae Kisumu strain , local wild pyrethroid-resistance An. funestus